CD4 and neoplasm: While there were more CD8+ T cells and CD4+ CD25+ CD127+ T-regulatory cells in letrozole-treated tumours, this was not statistically significant, and there were no significant differences between letrozole and vehicle mice in the percentages of other cells analysed (Additional file 7).